Venipuncture Needles And Syringes (Butterfly) Market

By Product;

Needles and Syringes

By Vein Type;

Cephalic Vein, Median Cubital Vein, Basilic Vein and Others

By End-User;

Hospitals, Blood Donation Camps and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn481454427 Published Date: August, 2025 Updated Date: September, 2025

Venipuncture Needles And Syringes Market Overview

Venipuncture Needles And Syringes Market (USD Million)

Venipuncture Needles And Syringes Market was valued at USD 1,232.89 million in the year 2024. The size of this market is expected to increase to USD 1,817.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.7%.


Venipuncture Needles And Syringes (Butterfly) Market

*Market size in USD million

CAGR 5.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.7 %
Market Size (2024)USD 1,232.89 Million
Market Size (2031)USD 1,817.40 Million
Market ConcentrationMedium
Report Pages329
1,232.89
2024
1,817.40
2031

Major Players

  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Smiths Medical (part of Smiths Group plc)
  • Nipro Corporation
  • Medtronic plc
  • Retractable Technologies, Inc.
  • Greiner Bio-One International GmbH
  • Vigmed AB (acquired by Greiner Bio-One)
  • Sarstedt AG & Co. KG

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Venipuncture Needles And Syringes (Butterfly) Market

Fragmented - Highly competitive market without dominant players


The Venipuncture Needles and Syringes (Butterfly) Market is gaining momentum as more healthcare professionals emphasize safer and more precise blood collection. Around 60% of medical staff now prefer butterfly systems for elderly and pediatric patients due to their reduced discomfort and greater control. This shift reflects the growing focus on patient-friendly procedures.

Emphasis on Safety and Efficiency
Safety features are becoming central to the market, with approximately 55% of devices now designed with protective mechanisms to reduce needle-stick incidents. Healthcare providers also report nearly 40% higher efficiency in blood collection procedures with butterfly needles compared to conventional venipuncture tools, reinforcing their widespread adoption.

Growing Role in Diagnostics
With laboratory testing expanding, nearly 65% of diagnostics depend on venipuncture samples, strengthening the demand for butterfly systems. Their ability to provide reliable, hemolysis-free samples makes them indispensable for accurate test results. This reliance ensures butterfly devices remain integral to diagnostic practices.

Preference for Disposable and Sterile Devices
Healthcare facilities are rapidly embracing single-use solutions, with about 70% adopting disposable butterfly needles and syringes to meet stringent infection control standards. The demand for sterile and patient-focused options continues to rise, driving a clear market shift toward safer disposable devices.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Vein Type
    3. Market Snapshot, By End-User
    4. Market Snapshot, By Region
  4. Venipuncture Needles And Syringes Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising healthcare expenditure
        2. Increasing prevalence of diseases
        3. Technological advancements in healthcare
        4. Growing geriatric population
        5. Demand for minimally invasive procedures
      2. Restraints
        1. Safety concerns
        2. Stringent regulatory requirements
        3. High cost of advanced needles
        4. Needlestick injuries
        5. Limited healthcare access in developing regions
      3. Opportunities
        1. Emerging markets expansion
        2. Innovations in needle design
        3. Shift towards outpatient care
        4. Increasing healthcare awareness
        5. Expansion of telemedicine services
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Venipuncture Needles And Syringes Market, By Product, 2021 - 2031 (USD Million)
      1. Needles
      2. Syringes
    2. Venipuncture Needles And Syringes Market, By Vein Type, 2021 - 2031 (USD Million)
      1. Cephalic Vein
      2. Median Cubital Vein
      3. Basilic Vein
      4. Others
    3. Venipuncture Needles And Syringes Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Blood Donation Camps
      3. Others
    4. Venipuncture Needles And Syringes Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. Canada
        2. United States
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Becton, Dickinson and Company (BD)
      2. Terumo Corporation
      3. B. Braun Melsungen AG
      4. Smiths Medical (part of Smiths Group plc)
      5. Nipro Corporation
      6. Medtronic plc
      7. Retractable Technologies, Inc.
      8. Greiner Bio-One International GmbH
      9. Vigmed AB (acquired by Greiner Bio-One)
      10. Sarstedt AG & Co. KG
  7. Analyst Views
  8. Future Outlook of the Market